Join us when CFO Kim Drapkin explains how she prioritizes the different aspects of her finance leadership role inside the biotech sector and reveals the different experiences that helped to prepare …
Continue Reading about 358: One Year After the IPO | Kim Drapkin, CFO, Jounce Therapeutics →